Mr Mark Beresford
Mark Beresford is a Consultant Clinical Oncologist working at the Royal United Hospital Bath, specialising in breast and urological malignancies.
Mark was appointed as a consultant in oncology at University Hospital Bristol in 2006, moving his NHS practice to Royal United Hospital Bath in 2011. He is active in clinical research at a national level, being principal investigator on many trials and an active member of the National Cancer Research Institute Breast Cancer Clinical Studies Group since 2010. He is an Honorary Senior Lecturer at Bristol University and Visiting Researcher at Bath University and has been awarded grants for local clinical trials. He is particularly interested in methods for early assessment of benefit from treatment.
Mark has advised NICE on the adoption and appraisal of new chemotherapy drugs, is a committee member of the British Uro-oncology Group and the Penny Brohn complimentary therapy centre. He is also a member of Innovators in Breast Cancer and Action for Bladder Cancer groups. He has personally authored over 50 scientific journal articles, conference posters and textbook chapters.